Entry |
|
Name |
Mubritinib (USAN/INN) |
Formula |
C25H23F3N4O2
|
Exact mass |
468.1773
|
Mol weight |
468.47
|
Structure |

|
Class |
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG01917 Receptor tyrosine kinase inhibitor
|
Efficacy |
Antineoplastic, Receptor tyrosine kinase inhibitor |
Target |
|
Pathway |
|
Interaction |
|
Brite |
Drug groups [BR:br08330]
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG01917 Receptor tyrosine kinase inhibitor
D04025 Mubritinib
Target-based classification of drugs [BR:br08310]
Protein kinases
Receptor tyrosine kinases (RTK)
EGFR family
ERBB2 (HER2, CD340)
D04025 Mubritinib (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 34
1 C8x C 23.1000 -24.4300
2 O2x O 24.5000 -24.4300
3 C8y C 24.9326 -23.0985
4 N5x N 23.8000 -22.2756
5 C8y C 22.6674 -23.0985
6 C2b C 26.1324 -22.4000
7 C2b C 27.3449 -23.1000
8 C8y C 28.5573 -22.4000
9 C8x C 29.7718 -23.1012
10 C8x C 30.9842 -22.4012
11 C8y C 30.9842 -21.0012
12 C8x C 29.7697 -20.3000
13 C8x C 28.5573 -21.0000
14 C1d C 32.2163 -20.2896
15 X F 33.4288 -19.5896
16 X F 32.9163 -21.5020
17 X F 31.5163 -19.0771
18 C1b C 21.4676 -22.4000
19 O2a O 20.2551 -23.1000
20 C8y C 19.0427 -22.4000
21 C8x C 19.0427 -21.0000
22 C8x C 17.8303 -20.3000
23 C8y C 16.6178 -21.0000
24 C8x C 16.6178 -22.4000
25 C8x C 17.8303 -23.1000
26 C1b C 15.3776 -20.3000
27 C1b C 14.1651 -21.0000
28 C1b C 12.9527 -20.3000
29 C1b C 11.7403 -21.0000
30 N4y N 10.5278 -20.3000
31 N5x N 10.3813 -18.9050
32 N5x N 9.0093 -18.6134
33 C8x C 8.3079 -19.8281
34 C8x C 9.2464 -20.8705
BOND 37
1 1 2 1
2 2 3 1
3 3 4 2
4 4 5 1
5 1 5 2
6 3 6 1
7 6 7 2
8 7 8 1
9 8 9 2
10 9 10 1
11 10 11 2
12 11 12 1
13 12 13 2
14 8 13 1
15 11 14 1
16 14 15 1
17 14 16 1
18 14 17 1
19 5 18 1
20 18 19 1
21 19 20 1
22 20 21 2
23 21 22 1
24 22 23 2
25 23 24 1
26 24 25 2
27 20 25 1
28 23 26 1
29 26 27 1
30 27 28 1
31 28 29 1
32 29 30 1
33 30 31 1
34 31 32 2
35 32 33 1
36 33 34 2
37 30 34 1
|